Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Polysaccharides | 2 | 2020 | 854 | 0.56 | Why? |
| Virulence | 1 | 2020 | 2172 | 0.48 | Why? |
| Epitopes | 2 | 2021 | 4113 | 0.39 | Why? |
| Antibodies, Neutralizing | 10 | 2021 | 25288 | 0.30 | Why? |
| AIDS Vaccines | 2 | 2020 | 452 | 0.27 | Why? |
| Antibodies, Monoclonal | 4 | 2021 | 8041 | 0.27 | Why? |
| Antibodies, Viral | 10 | 2021 | 51949 | 0.24 | Why? |
| Spike Glycoprotein, Coronavirus | 9 | 2021 | 37182 | 0.21 | Why? |
| Vaccines | 1 | 2020 | 3692 | 0.21 | Why? |
| Heme | 1 | 2021 | 110 | 0.21 | Why? |
| Bacterial Vaccines | 1 | 2020 | 139 | 0.18 | Why? |
| Glycosylation | 2 | 2020 | 1255 | 0.18 | Why? |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 314 | 0.17 | Why? |
| Proteolysis | 1 | 2021 | 751 | 0.16 | Why? |
| Myeloproliferative Disorders | 1 | 2021 | 507 | 0.16 | Why? |
| Plant Lectins | 1 | 2017 | 114 | 0.16 | Why? |
| Serologic Tests | 2 | 2020 | 4359 | 0.15 | Why? |
| Antigens, Differentiation | 1 | 2016 | 172 | 0.14 | Why? |
| T-Lymphocytes | 3 | 2021 | 6670 | 0.14 | Why? |
| Protein Processing, Post-Translational | 1 | 2018 | 634 | 0.14 | Why? |
| Structure-Activity Relationship | 1 | 2021 | 2219 | 0.14 | Why? |
| Leukocytes | 1 | 2020 | 1046 | 0.13 | Why? |
| Antibodies | 1 | 2020 | 846 | 0.13 | Why? |
| Mass Spectrometry | 1 | 2018 | 1165 | 0.12 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.12 | Why? |
| Dendritic Cells | 1 | 2020 | 1330 | 0.11 | Why? |
| Immunophenotyping | 3 | 2021 | 1290 | 0.11 | Why? |
| HIV | 1 | 2018 | 1116 | 0.11 | Why? |
| Hematologic Neoplasms | 2 | 2021 | 2105 | 0.11 | Why? |
| Membrane Proteins | 1 | 2021 | 1733 | 0.10 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.10 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.10 | Why? |
| Protein Conformation | 1 | 2021 | 4386 | 0.10 | Why? |
| Virus Internalization | 2 | 2021 | 7921 | 0.10 | Why? |
| Proteomics | 1 | 2021 | 2481 | 0.10 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.10 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.09 | Why? |
| Viral Tropism | 1 | 2016 | 1329 | 0.09 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.09 | Why? |
| Interferon Type I | 1 | 2021 | 2789 | 0.09 | Why? |
| Point-of-Care Systems | 1 | 2020 | 2955 | 0.08 | Why? |
| Protein Binding | 2 | 2021 | 11430 | 0.08 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.08 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.08 | Why? |
| B-Lymphocytes | 1 | 2020 | 4418 | 0.07 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.07 | Why? |
| HIV-1 | 2 | 2017 | 3365 | 0.07 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.07 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.06 | Why? |
| Neoplasms | 2 | 2021 | 17251 | 0.06 | Why? |
| Biliverdine | 1 | 2021 | 50 | 0.06 | Why? |
| Humans | 22 | 2021 | 930598 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.06 | Why? |
| HIV Antibodies | 2 | 2018 | 776 | 0.05 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.05 | Why? |
| Basophils | 1 | 2020 | 179 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 6653 | 0.05 | Why? |
| Twins | 1 | 2020 | 115 | 0.05 | Why? |
| Phosphoproteins | 2 | 2020 | 4346 | 0.05 | Why? |
| Virus Replication | 1 | 2021 | 14331 | 0.05 | Why? |
| Dose-Response Relationship, Immunologic | 1 | 2021 | 593 | 0.05 | Why? |
| Serum Amyloid P-Component | 1 | 2021 | 193 | 0.05 | Why? |
| Antigens, Neoplasm | 1 | 2021 | 230 | 0.05 | Why? |
| Cell Cycle | 1 | 2020 | 329 | 0.05 | Why? |
| Cross Infection | 1 | 2021 | 8675 | 0.05 | Why? |
| Protein Unfolding | 1 | 2018 | 47 | 0.05 | Why? |
| B-Lymphocyte Subsets | 1 | 2020 | 372 | 0.05 | Why? |
| Adult | 9 | 2021 | 244371 | 0.05 | Why? |
| Age of Onset | 1 | 2020 | 557 | 0.05 | Why? |
| Aged | 8 | 2021 | 215776 | 0.04 | Why? |
| Wales | 1 | 2021 | 758 | 0.04 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.04 | Why? |
| Bilirubin | 1 | 2021 | 503 | 0.04 | Why? |
| Nucleocapsid Proteins | 2 | 2020 | 3120 | 0.04 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.04 | Why? |
| Point Mutation | 1 | 2021 | 481 | 0.04 | Why? |
| Male | 11 | 2021 | 367725 | 0.04 | Why? |
| Musa | 1 | 2017 | 13 | 0.04 | Why? |
| Female | 11 | 2021 | 380317 | 0.04 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.04 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.04 | Why? |
| HEK293 Cells | 2 | 2021 | 8394 | 0.04 | Why? |
| Mutant Proteins | 1 | 2018 | 328 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2021 | 12361 | 0.04 | Why? |
| Hospitals | 3 | 2021 | 11793 | 0.04 | Why? |
| Protein Structure, Quaternary | 1 | 2018 | 455 | 0.04 | Why? |
| Immune Sera | 1 | 2021 | 884 | 0.04 | Why? |
| Chemokine CXCL10 | 1 | 2020 | 565 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2016 | 11041 | 0.04 | Why? |
| Syndrome | 1 | 2021 | 1310 | 0.04 | Why? |
| Gold | 1 | 2020 | 592 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.04 | Why? |
| Luminescent Measurements | 1 | 2020 | 924 | 0.04 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2018 | 556 | 0.04 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 7868 | 0.04 | Why? |
| Protein Engineering | 1 | 2018 | 536 | 0.04 | Why? |
| A549 Cells | 1 | 2021 | 2066 | 0.04 | Why? |
| London | 1 | 2021 | 2166 | 0.03 | Why? |
| Chemokines | 1 | 2020 | 1095 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2021 | 2689 | 0.03 | Why? |
| Antiviral Agents | 2 | 2017 | 41703 | 0.03 | Why? |
| False Negative Reactions | 1 | 2020 | 1785 | 0.03 | Why? |
| Cryoelectron Microscopy | 1 | 2021 | 2372 | 0.03 | Why? |
| Interleukin-10 | 1 | 2020 | 1409 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Metal Nanoparticles | 1 | 2020 | 771 | 0.03 | Why? |
| env Gene Products, Human Immunodeficiency Virus | 1 | 2016 | 386 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2020 | 9091 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2020 | 1387 | 0.03 | Why? |
| Cohort Studies | 3 | 2020 | 36005 | 0.03 | Why? |
| Up-Regulation | 1 | 2020 | 2249 | 0.03 | Why? |
| Biomarkers, Tumor | 1 | 2021 | 1314 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Flow Cytometry | 1 | 2020 | 2393 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.03 | Why? |
| Community Health Services | 1 | 2020 | 1000 | 0.03 | Why? |
| Protein Kinase Inhibitors | 1 | 2021 | 1585 | 0.03 | Why? |
| Protein Multimerization | 1 | 2017 | 1336 | 0.03 | Why? |
| Cardiomyopathies | 1 | 2020 | 997 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2020 | 2742 | 0.03 | Why? |
| Leukocyte Count | 1 | 2020 | 3178 | 0.03 | Why? |
| Sensitivity and Specificity | 2 | 2020 | 22971 | 0.02 | Why? |
| Genomics | 1 | 2021 | 3118 | 0.02 | Why? |
| England | 1 | 2020 | 5116 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.02 | Why? |
| Immunologic Memory | 1 | 2020 | 3362 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.02 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.02 | Why? |
| Binding Sites | 1 | 2017 | 6201 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.02 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.02 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.02 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Cell Line | 1 | 2016 | 12040 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.01 | Why? |
| Animals | 1 | 2021 | 78931 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
Doores's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(156)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(309)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_